Biopharma Supply Chains Adjust to Iran Conflict and Tariff Uncertainty Says Marken Strategy Chief

Dan Bell, chief strategy officer at Marken, addressed the impact of two major disruptions affecting global supply chain operations: the ongoing conflict in Iran and uncertainty surrounding international tariffs. Bell highlighted how biopharma companies and logistics teams are adapting to these challenges as they navigate an increasingly complex global trade environment.

Bell explained that the war in Iran has created significant instability in the region, leading to logistical hurdles for companies relying on supply routes through affected areas. This disruption has forced many organizations to reassess their transportation strategies and explore alternative routes to ensure continuity in their operations. Additionally, fluctuating tariff policies have introduced further unpredictability into global trade dynamics, prompting businesses to reevaluate cost structures and sourcing decisions. These dual challenges are compelling biopharma firms and logistics providers to adopt more flexible approaches while maintaining compliance with regulatory requirements.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI